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INTRODUCTION
Iodine is an essential micronutrient that is required for ade-
quate thyroid hormone production. In adults, mild-to-mod-
erate iodine deficiency appears to be associated with higher
rates of the more aggressive subtypes of thyroid cancer and
increased risk of diffuse goitre with the associated hypo-
thyroidism, nontoxic goitre and toxic nodular goitre (Anon-
ymous, 2008). Sufficient iodine intake is extremely impor-
tant during pregnancy, breastfeeding and early childhood
because even a mild iodine deficiency has the potential to
impair optimal brain development (Pearce et al., 2013;
Gowachirapant et al., 2009). According to the World Health
Organisation (WHO) guidelines, the median urinary iodine
concentration (UIC) in iodine-sufficient populations should
be greater than 100 µg/g Cr, and less than 20% of the popu-
lation can have a UIC below 50 µg/g Cr (Bernal and Nunez,
1995). Accordingly, mild iodine deficiency is defined as a
urinary iodine excretion of 50–99 µg/g Cr, moderate defi-
ciency as 20–49 µg/g Cr, and severe deficiency as less than
20 µg/g Cr (Ausó et al., 2004). Although the prevalence of
iodine deficiency in Europe has decreased by almost 30%
over the past decade, it still remains the leading cause of
preventable intellectual impairment (Gowachirapant et al.,
2009; Pearce et al., 2013) and is the primary motivation be-
hind the current worldwide drive to eliminate iodine defi-
ciency. The term iodine deficiency disorders (IDD) is used
to define a group of diseases resulting from a relative loss of
iodine in the diet, including those from multiple defects,
which may be prevented by ensuring adequate intake
(Anonymous, 2008; Huang et al., 2013). Despite good
health indicators in the European Union, IDD prevention
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In the absence of a mandatory salt iodisation programme, two nationwide cross-sectional cluster
surveys revealed persisting iodine deficiency among Latvian schoolchildren during the spring sea-
son and a noteworthy iodine deficiency in pregnant women in Latvia; these deficiencies warrant
intervention. The consequences of mild-to-moderate iodine deficiency during pregnancy and lac-
tation can adversely affect foetal brain development. Data from a Latvian population survey re-
vealed the consumption of approximately 100 µg of iodine per day through foods and iodised salt.
Therefore, strategies to increase the consumption of iodine-containing products should be imple-
mented, particularly for children. In addition, to meet the increased iodine requirement during
pregnancy, pregnant women should take daily supplements containing 150 µg iodine from the
earliest time possible. All women of childbearing age should be advised to increase their dietary
iodine intake by using iodised table salt and iodine-rich products: seafood, milk and milk products.
For women with pre-existing thyroid pathologies, the medical decision should be considered on a
case-by-case basis. Urinary iodine concentration monitoring among schoolchildren and pregnant
women and neonatal thyrotropin registry analysis every five years would be an appropriate strat-
egy for maintaining iodine intake within the interval that prevents iodine deficiency disorders.
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programmes have not been universally introduced, and parts
of Europe have poor or incomplete access to iodised salt
(Delange, 2002).
High-quality population data on iodine intake are required
to assess the population status and to design strategies to
correct deficiencies without introducing excessive intake.
During the last five years, two nationwide cross-sectional
cluster surveys on iodine nutrition have been performed in
Latvia (Konrade et al., 2012; 2015; 2014); these data serve
as the basis for national recommendations.
IODINE SOURCES
Iodine is obtained from the diet and is primarily absorbed
by the gastrointestinal tract in the inorganic anionic form of
iodide. Several studies have suggested that proximity to the
sea and seaweed abundance are factors that support an ade-
quate iodine supply, because seawater has the highest iodine
concentration of nearly 58 µg/L (Pessah-Pollack et al.,
2014). Because the Baltic Sea coast of Latvia extends for
more than 500 kilometres, iodine is a largely overlooked
nutrient in the country. The iodine cycling from seawater in
many regions is slow and incomplete; thus, soils and drink-
ing water are depleted of iodine, and populations in coastal
regions can also be iodine deficient (Bath et al., 2013). In
addition, foods of marine origin having the highest iodine
concentration are not widely used in everyday meals in Lat-
via (Grînberga et al., 2015). Most other foods and bever-
ages have low iodine content (Table 1); thus, iodine fortifi-
cation of table and industrial salt is the most convenient
option. The advantage of iodised salt is that it is used by
nearly all of society, irrespective of social and economic
status.
According to the results of salt consumption analysis in
1999, less than 1% of all edible salt in Latvia was iodised
(Selga et al., 2000); however, in 2014, the FinBalt study
found an approximately 10-fold increase: 6.9% of men and
9.4% of women reported an intake of iodised salt (Grîn-
berga et al., 2015). In 2010–2011, the self-reported preva-
lence of regular iodised salt consumption by Latvian
schoolchildren was similar, i.e., 10.2% (Konrade et al.,
2014).
Current efforts aimed at preventing iodine deficiency not
only stipulate iodisation of all household table salts but also
include other alternatives to increase the consumption of
iodine-rich marine and additional iodine-fortified products
(e.g., milk, mineral water) with standardised levels of iodine
(Moleti et al., 2011). In several countries, cow milk is con-
sidered an important source of dietary iodine (Konrade et
al., 2012), and associations between low urinary iodine ex-
cretion and a low intake of milk have been reported (Becker
et al., 2006).
Foods such as milk and bread are sources of iodine due to
the iodine-containing compounds used in agriculture and
the use of iodised salt in food preparation (Speeckaert et al.,
2011). In some countries, including the USA and Switzer-
land, the use of iodine-containing disinfectants or food sup-
plements in cow fodder are determined by local regulations.
However, no such regulations exist in Latvia. Consequently,
statistical data are not routinely collected. We conducted a
short survey of local farmers. We enrolled 37 farmers; 10
reported using iodophors, and 28 used iodine- fortified fod-
der. The median iodine content in the analysed samples was
546.9 (IQR 311.9; 759.2) µg/L (Neimane, unpublished
data). There was wide variation of iodine concentration
ranging from 212.6 to 1298.7 µg/L. Milk samples were col-
lected in both winter and summer, and the iodine content
was similar among seasons. The fat content of milk did not
correlate significantly with iodine concentration. However,
a larger sample size would be necessary to verify these re-
sults. Nevertheless, our recent study showed that the median
UIC was significantly lower in women who reported only
rare milk product consumption than in women who con-
sumed approximately three servings of milk products daily
(Konrade et al., 2015).
Dietary supplements are a significant source of iodine, espe-
cially during pregnancy. Our studies revealed that less than
20% of pregnant women reported the use of iodine-contain-
ing supplements, and only 6.8 % used supplements with an
iodine content of  150 µg; this supplementation resulted in
a slightly higher median UIC compared with those of the
group of women who did not use iodine-containing supple-
ments and those who used supplements with an iodine con-
tent of < 100 µg (Konrade et al., 2015). These findings indi-
cate that iodine-containing supplements, dairy products and
iodised salt are the most important iodine sources in Latvia.
IMPORTANCE OF ADEQUATE IODINE NUTRITION
Iodine deficiency occurs when the iodine intake does not
meet the recommended levels. The term IDD is used to de-
scribe the consequences of iodine deficiency in a popula-
T a b l e 1
IODINE CONTENT IN 100 GRAMS OF FOOD (Dahl et al., 2009)





Sardine, in tomato sauce, canned 67
Salmon, farmed, raw 44




Cheese (45%, Edam, Cheddar) 13–75
Potatoes 2
Fruits and berries 2
* Content may vary according to the geographical area and the iodine con-
tent of the soil
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tion; this deficiency may be prevented by ensuring adequate
iodine intake (Anonymous, 2008; Rohner et al., 2014). In
the adult population, iodine deficiency is associated with an
increased rate of goiter, hyperfunctioning thyroid nodules,
hypothyroidism, and diminished working ability and pro-
ductivity. Regardless of age, there is also a latent risk of in-
creased thyroid susceptibility to nuclear radiation. IDD is
associated with a higher incidence rate of thyroid cancer
and with an altered ratio of papillary to follicular neoplasia.
In the state of iodine sufficiency, a significant predomi-
nance of papillary carcinoma is observed. This alteration
means that, in fact, thyroid cancer subtypes shift towards
more malignant forms (de Benoist et al., 2009).
However, the most significant effects result from insuffi-
cient iodine levels during pregnancy and the immediate
postpartum period. A meta-analysis published in 2013 re-
vealed that at age 5, children lost 7.4 IQ points due to iodine
deficiency during pregnancy (Bougma et al., 2013). Econo-
metric models have established that this result not only is
significant at the individual level but also affects society as
a whole: a one-point decrease in IQ has been associated
with a persistent 0.11% annual decrease in per capita gross
domestic product (GDP). This effect is connected with an
economic recession and translates into a decrease in produc-
tivity (Jones and Schneider, 2006). These substantial conse-
quences result from even mild iodine deficiency, which dis-
rupts the metabolism of thyroid hormones — a critical
endocrine regulator of early brain development (Bernal and
Nunez, 1995). The thyroid hormone regulates a specific
gene underlying major neurodevelopmental events. This ef-
fect plays a significant role in neurogenesis, axon and den-
drite formation, neuronal migration, synaptogenesis and
myelination (Berbel et al., 1985; Berbel et al., 1994;
Morreale De Escobar et al., 2000; Ausó et al., 2004; Cuevas
et al., 2005). Furthermore, thyroid hormones are a key regu-
lator of the basal metabolic rate and macronutrient metabo-
lism (Oppenheimer et al., 1987).
IODINE STATUS IN CHILDREN
The first nationwide cross-sectional school-based cluster
survey of IDD in Latvia was performed in 2000, when 587
schoolchildren were tested. The survey revealed a median
UIC of 59 µg/L, which was indicative of a mild iodine defi-
ciency; severe iodine deficiency was observed in 19.2%
(n = 115) of the participants (Selga et al., 2000). Addi-
tionally, the Latvian neonatal thyrotropin (TSH) screening
data from 2000–2002 provided evidence that Latvia is an
iodine-deficient region (Gyurjyan et al., 2006).
A 10-year follow-up cross-sectional interseasonal school-
based cluster survey was performed in October 2010 and
April 2011 (Fig. 1). In addition, as a tool to monitor iodine
deficiency during pregnancy, the Latvian Neonatal TSH
screening data (prevalence of TSH 5 mIU/L) from 31,274
newborns in 2009–2010 were analysed. The UIC was found
to be at the lower end of the normal range (107.3 µg/g)
(Konrade et al., 2014), which can be considered an im-
provement compared with results of the previous nation-
wide cross-sectional school study (Selga et al., 2000). Simi-
lar to the results of other studies conducted in mild iodine-
deficient regions of Europe (Als et al., 2003; Moreno-Reyes
et al., 2011; Arrizabalaga et al., 2012), we found seasonal
UIC fluctuations. In autumn, the UIC was at the lower end
of the normal range (129.7 µg/g Cr), but it was significantly
lower during the spring sampling (78.3 µg/g Cr) (Konrade
et al., 2014). Interestingly, our study results showed fluctua-
tions opposite to those of the previously cited publications
that showed a higher UIC in spring. The data from the Na-
tional Neonatal TSH Registry also confirmed seasonal dif-
ferences in iodine levels and iodine deficiency in Latvia. In-
creased TSH levels were present in 8.7% of neonates, also
indicating inadequate iodine nutrition and being in agree-
ment with the measures of iodine status determined by UIC
analysis (Konrade et al., 2014). Nevertheless, the result was
significantly better than the rate of 16.5% found during the
Latvian Neonatal TSH screening in 2000–2002 (Gyurjyan
et al., 2006).
In conclusion, some degree of iodine deficiency is present
in 49% of Latvian schoolchildren, especially in urban
schools and in the Latgale and Vidzeme regions.
IODINE STATUS IN PREGNANCY
A study of pregnant women in Latvia found a median UIC
of 80.8 µg/g Cr, indicating substantial iodine deficiency,
and the data supported the notion that iodine deficiency al-
ready existed before pregnancy (Konrade et al., 2015). The
median UIC was significantly higher in the second and third
trimesters, which was attributed to the intake of iodine-con-
taining supplements (Konrade et al., 2015). Contrary to the
finding of no seasonality effect in the UIC values, the ele-
vated TPO-Ab concentration was approximately two times
higher in spring than in autumn (Konrade et al., 2015). In
addition, we did not observe any association between UIC
and elevated TPO-Ab values. Because more than 80% of
the pregnant women had UICs lower than 150 µg/g Cr, the
Fig. 1. Urinary iodine concentration (UIC) in Latvian schoolchildren (dark
grey) and pregnant women (light grey). The striped columns represent UIC
values below the normal range of the respective population, and the solid
coloured columns are within the normal range. Cluster survey of school-
children performed in October 2010 and April 2011 (Konrade et al., 2014),
and national survey of pregnant women carried out during the spring and
autumn seasons in 2013 (Konrade et al., 2015).
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iodine supplementation was not expected to trigger thyroid
autoimmunity, a result that has been observed in popula-
tions with UICs that were approximately three times greater
(Guan et al., 2005). In countries such as Latvia, excessive
iodine intake is unlikely, even with regular consumption of
iodised salt at the WHO recommended amount of 5 g/day
(Anonymous, 2014) and seafood once weekly.
IODIZATION PROGRAMME-RELATED RISKS
The WHO recommended daily dose of iodine is 150 µg for
adults, which is approximately three times the amount
(52 µg) of iodine that the thyroid must take up daily to re-
main in balance (Bürgi, 2010). Depending on the availabil-
ity of iodine, a healthy thyroid gland is able to enhance or
limit the use of iodine for thyroid hormone production for a
limited period. However, epidemiological studies have
linked even a cautious iodisation programme in countries
with previous moderate or mild iodine deficiency to the de-
velopment of hypothyroidism (Pedersen et al., 2007; Li et
al., 2008). Furthermore, in almost all cases, this phenome-
non had an autoimmune basis (Markou et al., 2001). In this
context, previous animal model studies have connected in-
duction of disease processes with thyroglobulin (Tg) iodin-
ation, because observations showed that hypo-iodinated Tg
did not activate T cells; however, increasing the Tg iodine
content to even normal levels in vitro led to the antigenicity
of the molecule (Barin et al., 2005). Iodide may epi-
genetically modify the Tg molecule and create iodinated
neoantigenic determinants to which immune tolerance has
not been established, or it may act via apoptotic/necrotic ef-
fects of thyrocytes, thus initiating the presentation of thy-
roid antigens that can activate T cells (Markou et al., 2001).
Whether the pathological process will begin and which
pathway will dominate depend on the genetic background.
A sudden increase in iodine intake in an iodine-deficient
population may increase thyroid autoimmunity (Kahaly et
al., 1998; Pedersen et al., 2007; 2011). One of the best and
most studied examples is in Denmark, where iodine fortifi-
cation of salt was introduced in 1998. In Aalborg, where
the median UIC was 45 µg/L at the beginning of the
programme, the incidence of hypothyroidism increased; in
contrast, in Copenhagen, there was a mild iodine deficiency
(61 µg/L) at the beginning of the programme, and the in-
crease was not significant (Pedersen et al., 2007). Overt
hypothyroidism occurred most often in young and mid-
dle-aged subjects with previous moderate iodine deficiency.
Moreover, after five years of the public iodisation
programme, the rate of TPO-Ab 30 U/mL in the Danish
population increased from 14.3% to 23.8%, and statistical
significance was confirmed in multivariate regression mod-
els. In this study (Pedersen et al., 2007), the TPO-Ab in-
crease was most pronounced in young women and for the
lower antibody concentrations. Nonetheless, the possibility
that this result was at least partly a transient phenomenon
must be considered (Zimmermann et al., 2003); therefore,
further studies are needed to evaluate the long-term effects
and clinical consequences.
AN OPTIMAL STRATEGY FOR THE DETECTION OF
AUTOIMMUNE THYROID DISEASE IN PREGNANCY
One solution for effective and safe iodine supplementation
during pregnancy would be universal screening for autoim-
mune thyroid disease (AITD) with TSH and TPO-Ab detec-
tion at the first antenatal appointment. While the Latvian
healthcare system is cutting laboratory testing expenses,
such a recommendation would not gain regulatory accep-
tance. Thyroid, endocrine and obstetrics professional or-
ganisations have also prepared position statements on this
issue; however, universal screening for thyroid disease dur-
ing pregnancy is controversial, with strong proponents on
both sides (Glinoer, 1998; Casey, 2006; Brent, 2007).
It is evident that thyroid disease has multiple adverse effects
during pregnancy and the postpartum period, and in the de-
veloping foetus. These effects include miscarriage (Glinoer
et al., 1991), preterm delivery (Stagnaro-Green et al.,
2005), decreased intelligence quotient (Pop et al., 1999) and
visual-motor deficiencies (Zoeller and Rovet, 2004) in the
offspring, especially in women with elevated serum anti-
thyroid antibody titres (Stagnaro-Green and Glinoer, 2004).
Women with thyroid autoimmunity are also at an increased
risk for postpartum thyroiditis (Muller et al., 2001) and the
development of overt hypothyroidism in the future (Vander-
pump et al., 1995). Despite the lack of effective strategies to
decrease maternal and foetal complications for pregnant
women with thyroid abnormalities (Negro et al., 2010),
most professional associations recommend case finding for
pregnant women who are identified as having a high risk for
thyroid disease: family or personal history of autoimmune
disease, history of neck irradiation, or previous miscarriages
or preterm deliveries (Abalovich et al., 2007; Anonymous,
2007). Nonetheless, research data reveal that such practice
may miss 30–50% of the hypothyroid cases (Vaidya et al.,
2007; Horacek et al., 2010). A literature review found
analyses stating that universal screening of pregnant women
for AITD is cost effective compared with no screening (Do-
siou et al., 2008; Thung et al., 2009). Moreover, studies
have shown that universal screening is also highly cost ef-
fective compared with high-risk screening only (Dosiou et
al., 2012).
According to epidemiological study data, thyroidal auto-
immunity affects approximately 11% of women of repro-
ductive age (Hollowell et al., 2002), and this proportion was
also observed in Latvia (Konrade et al., 2015). To improve
obstetric outcomes and gain child IQ benefits in the setting
of established iodine deficiency, a universal screening mea-
suring TSH and TPO-Ab levels would allow personalised
iodine supplementation recommendations.
RECOMMENDATIONS
In the absence of a mandatory salt iodisation programme,
there is a persisting iodine deficiency among Latvian
schoolchildren during the spring season and a noteworthy
iodine deficiency in pregnant women in Latvia, which war-
rant intervention.
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The strategies for increasing the consumption of iodine-
containing products to approximately 150 µg should be im-
proved, particularly for children. Therefore, initiatives, such
as the School Milk Programme and the use of iodinated salt
in both school and household kitchens, will improve iodine
nutrition.
Because mild to moderate iodine deficiency during preg-
nancy and the lactation period can adversely affect foetal
brain development, WHO-UNICEF and ICCIDD advise an
increase in the recommended daily dosage of iodine to 250
µg/day for pregnant women and breastfeeding women and
150 µg/day for women in the preconception period (Anony-
mous, 2008).
An adequate iodine status is important even before fertilisa-
tion and pregnancy. All women of childbearing age should
be advised to increase their dietary iodine intake through the
use of iodised table salt and dairy products and the con-
sumption of seafood twice weekly.
Data from a survey of the Latvian population indicate that
approximately 100 µg of iodine per day is consumed
through foods and iodised salt. To meet the increased iodine
requirement in pregnancy, pregnant women should take a
supplement containing 150 µg of iodine daily from the ear-
liest time possible.
Breast milk is an important source of iodine to maintain
thyroid function in infants, who are highly dependent on
maternal iodine nutrition during breast feeding. Therefore,
in addition to dietary iodine sources, iodine supplementa-
tion of 150 µg daily is recommended for breastfeeding
women.
Whilst the importance of gestational iodine supplementation
is undisputed, we believe that in mild-moderate iodine-
deficient areas, such as Latvia, women considering concep-
tion who do not have adequate iodine intake through diet
should be advised to consume iodine supplements for sev-
eral months prior to pregnancy.
Iodine supplements may be contraindicated for women with
certain pre-existing thyroid pathologies; the medical deci-
sion, which is taken on a case-by-case basis, is made by the
physician.
UIC monitoring among schoolchildren and pregnant women
and neonatal TSH registry analysis every five years will
provide appropriate indicators for iodine intake to help keep
UIC values within, but not higher than, the range that pre-
vents IDD.
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JODA DEFICÎTS LATVIJÂ: PAÐREIZÇJAIS STÂVOKLIS UN NEPIECIEÐAMÎBA PÇC JAUNÂM NACIONÂLAJÂM
REKOMENDÂCIJÂM
Apstâkïos, kad Latvijâ nav obligâtas sâls jodçðanas programmas, divi nacionâlie ðíçrsgriezuma klasteru apsekojumi atklâjuði joda deficîtu
Latvijas skolçniem pavasara sezonâ un bûtisku joda deficîtu grûtniecçm Latvijâ; ðis deficîts prasa iejaukðanos. Viegla un mçrena joda
deficîta sekas grûtniecîbas un baroðanas ar krûti laikâ var nevçlami ietekmçt augïa smadzeòu attîstîbu. Saskaòâ ar datiem no Latvijas
iedzîvotâju apsekojuma dienâ ar çdienu un jodçto sâli tiek uzòemti apmçram 100 µg joda. Tâpçc bûtu nepiecieðama stratçìija jodu saturoðu
produktu patçriòa palielinâðanai, it îpaði bçrniem. Turklât, lai sasniegtu palielinâto joda pieprasîjumu grûtniecîbas laikâ, grûtniecçm pçc
iespçjas agrâk jâsâk lietot uztura bagâtinâtâjus, kas satur vismaz 150 µg joda. Visâm reproduktîvâ vecuma sievietçm jâiesaka palielinât joda
uzòemðanu ar çdienu, lietojot jodçto sâli un produktus, kas satur daudz joda: jûras veltes, pienu un piena produktus. Sievietçm ar jau esoðu
vairogdziedzera slimîbu medicîniskais lçmums jâizdara katrâ gadîjumâ atseviðíi. Joda koncentrâcijas mçrîðana urînâ skolçniem un
grûtniecçm un jaundzimuðo vairogdziedzeri stimulçjoðâ hormona (TSH) reìistra analîze ik pçc pieciem gadiem bûtu piemçrota stratçìija
joda nodroðinâjuma uzturçðanai intervâlâ, kas novçrð joda deficîta radîtos traucçjumus.
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